Nuvation’s Safusidenib Shows Durable Benefit, With Key 2027 Readouts Ahead
at www.tipranks.com (Mon, 16-Nov 11:55 AM)
Nuvation Bio Earnings Call Highlights IBTROZI Momentum
at www.tipranks.com (Sat, 14-Nov 8:43 PM)
NUVB highlights nearly 50-month median response as FDA updates IBTROZI label ahead of schedule
Market Chameleon (Fri, 18-Sep 11:41 AM)
NUVB Wins FDA Label Update for IBTROZI Highlighting 49.70-Month Median Response Duration
Market Chameleon (Thu, 17-Sep 7:54 AM)
Market Chameleon (Thu, 20-Aug 8:59 AM)